Abstract
Aim: This study aims to determine the effects of vitamin D (25-OH D), vitamin B12, and folic acid levels on the development and severity of the disease in pediatric COVID-19 patients.
Methods: The files of 104 pediatric patients aged 0-17 years who applied to the pediatric service of our hospital with the suspicion of COVID-19 were reviewed retrospectively. Patients with positive PCR tests belong to the COVID-19 group (Group P), and patients with negative PCR tests were included in the control group (Group C). Patients diagnosed with COVID-19 were further divided into two groups: low vitamin D (Group I) and normal vitamin D (Group II).
Results: The levels of vitamin D (25-OH D) and B12 were statistically significantly lower in the COVID-19 patient group (p<0.05).
Conclusion: We think that adequate vitamin B12 and vitamin D (25-OH) levels in children may be important in fighting against the COVID-19 infection.
Keywords: COVID-19, children, vitamin D, vitamin B12
Copyright and license
Copyright (c) 2022 The Author(s). This is an open-access article published by Bolu İzzet Baysal Training and Research Hospital under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
